Pathology · Neoplasia (Classification, Carcinogenesis, Tumor Markers, Paraneoplastic)

A patient with medullary thyroid carcinoma has elevated serum calcitonin. Which additional tumor marker, if elevated, suggests co-existing pheochromocytoma in MEN 2A?

  • A Urinary catecholamines and metanephrines
  • B CEA
  • C CA 19-9
  • D Serum PTH
Correct answer: A. Urinary catecholamines and metanephrines

Explanation

MEN 2A (Sipple syndrome) comprises medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism. Pheochromocytoma is screened by measuring urinary catecholamines and metanephrines (or plasma free metanephrines). CEA can be elevated in medullary thyroid cancer but does not screen for pheochromocytoma; PTH elevation would indicate the parathyroid component.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Neoplasia (Classification, Carcinogenesis, Tumor Markers, Paraneoplastic) MCQs

See all Neoplasia (Classification, Carcinogenesis, Tumor Markers, Paraneoplastic) MCQs →